Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children’s Oncology Group (COG)

Hardy KK, Embry L, Kairalla JA, Sharkey C, Gioia AR, Griffin D, Berger C, Weisman HS, Noll RB, Winick NJ. Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children’s Oncology Group (COG). Pediatr Blood Cancer. 2024 Nov;71(11):e31179. doi: 10.1002/pbc.31179. Epub 2024 Aug 23. PMID: 39175358; PMCID: PMC11708892.

Survivors of childhood B-acute lymphoblastic leukemia (B-ALL) are at risk for difficulties with attention and executive functioning (EF) as a late effect of treatment. The present study aimed to identify treatment and demographic factors associated with risk for difficulties with executive functioning in youth treated for high-risk B-ALL.